Segurança e Eficácia da Terapia com Células-tronco Mesenquimais Derivadas do Tecido Adiposo para Cardiopatia Isquêmica: Revisão Sistemática

Resumo Fundamento A terapia celular utilizando células-tronco mesenquimais derivadas do tecido adiposo (ADSC, sigla em inglês) apresenta grande potencial como tratamento para doenças cardiovasculares. Objetivo Realizamos uma revisão sistemática para descrever a segurança e a eficácia das ADSC na car...

Full description

Saved in:
Bibliographic Details
Published inArquivos brasileiros de cardiologia Vol. 121; no. 9
Main Authors Giugni, Fernando Rabioglio, Giugni, Melina de Oliveira Valdo, Pinesi, Henrique Trombini, Habrum, Fabio Cetinic, Laranjeira, Lígia Nasi, Sady, Erica Regina Ribeiro, Suzumura, Erica Aranha, Gowdak, Luis Henrique Wolff, Krieger, José Eduardo
Format Journal Article
LanguagePortuguese
English
Published Sociedade Brasileira de Cardiologia - SBC 2024
Sociedade Brasileira de Cardiologia (SBC)
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Resumo Fundamento A terapia celular utilizando células-tronco mesenquimais derivadas do tecido adiposo (ADSC, sigla em inglês) apresenta grande potencial como tratamento para doenças cardiovasculares. Objetivo Realizamos uma revisão sistemática para descrever a segurança e a eficácia das ADSC na cardiopatia isquêmica. Métodos Pesquisamos na PubMed/MEDLINE, EMBASE, Web of Science, CENTRAL e LILACS (desde o início até março de 2024) por estudos clínicos envolvendo ADSC em pacientes com cardiopatia isquêmica. Excluímos estudos envolvendo pacientes com outros tipos de doenças cardíacas, estudos utilizando células-tronco mesenquimais derivadas de outros tecidos, bem como estudos em andamento. Dois revisores independentes realizaram a triagem das citações recuperadas, extraíram dados relevantes e avaliaram o risco de viés nos ensaios incluídos, utilizando os critérios da Colaboração Cochrane modificados pela Universidade McMaster e o Índice Metodológico para Estudos Não-Randomizados (MINORS). Utilizamos uma síntese narrativa para apresentar os resultados. Resultados Dez estudos (compreendendo 29 publicações) preencheram nossos critérios de inclusão, incluindo 8 ensaios controlados randomizados e 2 ensaios não controlados. Não foram relatados eventos adversos graves associados à terapia com ADSC. Embora a maioria dos desfechos de eficácia não tenha alcançado significância estatística, houve relatos de melhora da área isquêmica, capacidade funcional, sintomas e contratilidade em pacientes tratados com ADSC. Conclusões Os resultados da nossa revisão sugerem que a terapia com ADSC é geralmente segura para pacientes com cardiopatia isquêmica. Contudo, são necessárias mais investigações para confirmar a sua eficácia, particularmente em ensaios clínicos de maior escala e em condições específicas onde as melhorias na microcirculação podem ter um impacto notável nos desfechos clínicos. Abstract Background Cell therapy using adipose-derived mesenchymal stem cells (ADSCs) shows great potential as a treatment for cardiovascular diseases. Objective We conducted a systematic review to describe the safety and efficacy of ADSCs in ischemic heart disease. Methods We searched PubMed/MEDLINE, EMBASE, Web of Science, CENTRAL, and LILACS (from inception to March 2024) for clinical studies involving ADSCs in patients with ischemic heart disease. We excluded studies involving patients with other types of heart disease, studies using mesenchymal stem cells derived from other tissues, as well as ongoing studies. Two independent reviewers screened the retrieved citations, extracted relevant data, and assessed the risk of bias in the included trials, using the Cochrane Collaboration criteria modified by McMaster University and Methodological Index for Non-Randomized Studies (MINORS). We used a narrative synthesis to present the results. Results Ten studies (comprising 29 publications) met our inclusion criteria, including 8 randomized controlled trials and 2 uncontrolled trials. No severe adverse events associated with ADSC therapy were reported. While most efficacy endpoints did not reach statistical significance, there were reports of improved ischemic area, functional capacity, symptoms, and contractility in patients treated with ADSCs. Conclusions The findings from our review suggest that ADSC therapy is generally safe for patients with ischemic heart disease. However, further investigation is warranted to confirm its efficacy, particularly with larger clinical trials and in specific conditions where improvements in microcirculation may have a notable impact on clinical outcomes.
AbstractList Resumo Fundamento A terapia celular utilizando células-tronco mesenquimais derivadas do tecido adiposo (ADSC, sigla em inglês) apresenta grande potencial como tratamento para doenças cardiovasculares. Objetivo Realizamos uma revisão sistemática para descrever a segurança e a eficácia das ADSC na cardiopatia isquêmica. Métodos Pesquisamos na PubMed/MEDLINE, EMBASE, Web of Science, CENTRAL e LILACS (desde o início até março de 2024) por estudos clínicos envolvendo ADSC em pacientes com cardiopatia isquêmica. Excluímos estudos envolvendo pacientes com outros tipos de doenças cardíacas, estudos utilizando células-tronco mesenquimais derivadas de outros tecidos, bem como estudos em andamento. Dois revisores independentes realizaram a triagem das citações recuperadas, extraíram dados relevantes e avaliaram o risco de viés nos ensaios incluídos, utilizando os critérios da Colaboração Cochrane modificados pela Universidade McMaster e o Índice Metodológico para Estudos Não-Randomizados (MINORS). Utilizamos uma síntese narrativa para apresentar os resultados. Resultados Dez estudos (compreendendo 29 publicações) preencheram nossos critérios de inclusão, incluindo 8 ensaios controlados randomizados e 2 ensaios não controlados. Não foram relatados eventos adversos graves associados à terapia com ADSC. Embora a maioria dos desfechos de eficácia não tenha alcançado significância estatística, houve relatos de melhora da área isquêmica, capacidade funcional, sintomas e contratilidade em pacientes tratados com ADSC. Conclusões Os resultados da nossa revisão sugerem que a terapia com ADSC é geralmente segura para pacientes com cardiopatia isquêmica. Contudo, são necessárias mais investigações para confirmar a sua eficácia, particularmente em ensaios clínicos de maior escala e em condições específicas onde as melhorias na microcirculação podem ter um impacto notável nos desfechos clínicos.
Resumo Fundamento A terapia celular utilizando células-tronco mesenquimais derivadas do tecido adiposo (ADSC, sigla em inglês) apresenta grande potencial como tratamento para doenças cardiovasculares. Objetivo Realizamos uma revisão sistemática para descrever a segurança e a eficácia das ADSC na cardiopatia isquêmica. Métodos Pesquisamos na PubMed/MEDLINE, EMBASE, Web of Science, CENTRAL e LILACS (desde o início até março de 2024) por estudos clínicos envolvendo ADSC em pacientes com cardiopatia isquêmica. Excluímos estudos envolvendo pacientes com outros tipos de doenças cardíacas, estudos utilizando células-tronco mesenquimais derivadas de outros tecidos, bem como estudos em andamento. Dois revisores independentes realizaram a triagem das citações recuperadas, extraíram dados relevantes e avaliaram o risco de viés nos ensaios incluídos, utilizando os critérios da Colaboração Cochrane modificados pela Universidade McMaster e o Índice Metodológico para Estudos Não-Randomizados (MINORS). Utilizamos uma síntese narrativa para apresentar os resultados. Resultados Dez estudos (compreendendo 29 publicações) preencheram nossos critérios de inclusão, incluindo 8 ensaios controlados randomizados e 2 ensaios não controlados. Não foram relatados eventos adversos graves associados à terapia com ADSC. Embora a maioria dos desfechos de eficácia não tenha alcançado significância estatística, houve relatos de melhora da área isquêmica, capacidade funcional, sintomas e contratilidade em pacientes tratados com ADSC. Conclusões Os resultados da nossa revisão sugerem que a terapia com ADSC é geralmente segura para pacientes com cardiopatia isquêmica. Contudo, são necessárias mais investigações para confirmar a sua eficácia, particularmente em ensaios clínicos de maior escala e em condições específicas onde as melhorias na microcirculação podem ter um impacto notável nos desfechos clínicos. Abstract Background Cell therapy using adipose-derived mesenchymal stem cells (ADSCs) shows great potential as a treatment for cardiovascular diseases. Objective We conducted a systematic review to describe the safety and efficacy of ADSCs in ischemic heart disease. Methods We searched PubMed/MEDLINE, EMBASE, Web of Science, CENTRAL, and LILACS (from inception to March 2024) for clinical studies involving ADSCs in patients with ischemic heart disease. We excluded studies involving patients with other types of heart disease, studies using mesenchymal stem cells derived from other tissues, as well as ongoing studies. Two independent reviewers screened the retrieved citations, extracted relevant data, and assessed the risk of bias in the included trials, using the Cochrane Collaboration criteria modified by McMaster University and Methodological Index for Non-Randomized Studies (MINORS). We used a narrative synthesis to present the results. Results Ten studies (comprising 29 publications) met our inclusion criteria, including 8 randomized controlled trials and 2 uncontrolled trials. No severe adverse events associated with ADSC therapy were reported. While most efficacy endpoints did not reach statistical significance, there were reports of improved ischemic area, functional capacity, symptoms, and contractility in patients treated with ADSCs. Conclusions The findings from our review suggest that ADSC therapy is generally safe for patients with ischemic heart disease. However, further investigation is warranted to confirm its efficacy, particularly with larger clinical trials and in specific conditions where improvements in microcirculation may have a notable impact on clinical outcomes.
Author Suzumura, Erica Aranha
Pinesi, Henrique Trombini
Sady, Erica Regina Ribeiro
Giugni, Fernando Rabioglio
Laranjeira, Lígia Nasi
Habrum, Fabio Cetinic
Krieger, José Eduardo
Giugni, Melina de Oliveira Valdo
Gowdak, Luis Henrique Wolff
AuthorAffiliation Hospital do Coração
Baylor University Medical Center at Dallas
The University of Texas Southwestern Medical Center
Universidade de São Paulo
AuthorAffiliation_xml – name: Universidade de São Paulo
– name: The University of Texas Southwestern Medical Center
– name: Hospital do Coração
– name: Baylor University Medical Center at Dallas
Author_xml – sequence: 1
  givenname: Fernando Rabioglio
  orcidid: 0000-0001-9268-286X
  surname: Giugni
  fullname: Giugni, Fernando Rabioglio
  organization: The University of Texas Southwestern Medical Center, EUA; Universidade de São Paulo, Brasil
– sequence: 2
  givenname: Melina de Oliveira Valdo
  surname: Giugni
  fullname: Giugni, Melina de Oliveira Valdo
  organization: Universidade de São Paulo, Brasil; Baylor University Medical Center at Dallas, EUA
– sequence: 3
  givenname: Henrique Trombini
  surname: Pinesi
  fullname: Pinesi, Henrique Trombini
  organization: Universidade de São Paulo, Brasil
– sequence: 4
  givenname: Fabio Cetinic
  surname: Habrum
  fullname: Habrum, Fabio Cetinic
  organization: Universidade de São Paulo, Brasil
– sequence: 5
  givenname: Lígia Nasi
  surname: Laranjeira
  fullname: Laranjeira, Lígia Nasi
  organization: Hospital do Coração, Brasil
– sequence: 6
  givenname: Erica Regina Ribeiro
  orcidid: 0000-0003-2390-1605
  surname: Sady
  fullname: Sady, Erica Regina Ribeiro
  organization: Hospital do Coração, Brasil
– sequence: 7
  givenname: Erica Aranha
  surname: Suzumura
  fullname: Suzumura, Erica Aranha
  organization: Universidade de São Paulo, Brasil
– sequence: 8
  givenname: Luis Henrique Wolff
  surname: Gowdak
  fullname: Gowdak, Luis Henrique Wolff
  organization: Universidade de São Paulo, Brasil
– sequence: 9
  givenname: José Eduardo
  surname: Krieger
  fullname: Krieger, José Eduardo
  organization: Universidade de São Paulo, Brasil; Hospital do Coração, Brasil
BookMark eNo9UcFu1DAQtVCR2BaO3P0DWSaxk9jcqqXASkVIbJG4WRN7UnmVjVN7t1I_g0-oOFTlN_JjuF3gMjN60nt6894pOxnDSIy9LWEpmqaBd9jZZQWVACXgBVuUTasKWbZwwhYATVO0qvrxip2mtAWoqlbUC_ZzQ9eHiOP8gJz4Re_tfG89cof8iiJO-bRhx1fz43AYMBX7GEYb-BdKNN4c_A594h8o-lt0mLgLmWV9XufOTyEFPmFEvsLofJhwn9XW6eYw_955i-_5N7r1af4V-ManPe3m-32GX7OXPQ6J3vzdZ-z7x4ur1efi8uun9er8srClFDJPTZqcc53WJMqaHPbaYg3K6QartlVka6UdWdU5kND3VqC2wnWy7DuH4oytj7ou4NZMMf8S70xAb56BEK8NxmxoICNrXfVW1dhBJ7HpUQqtGu2wIkUgddZaHrWS9TQEsw2HOGbzZvOUu3nKPfciAUADCJCZUBwJNoaUIvX_DZRgnss0uUzzr0zxB8ISmRs
Cites_doi 10.1161/CIRCINTERVENTIONS.120.009002
10.1016/j.jacc.2022.11.061
10.1186/s12967-019-2110-1
10.1001/jama.2012.25321
10.1179/2045772315Y.0000000048
10.1155/2017/5237063
10.5603/KP.2018.0097
10.1371/journal.pmed.1000097
10.1161/CIRCRESAHA.114.303180
10.1002/ejhf.1412
10.1016/j.ymeth.2008.03.006
10.3390/ijms22041538
10.1038/gt.2009.146
10.5966/sctm.2014-0253
10.1371/journal.pone.0006005
10.1016/j.jcyt.2015.03.608
10.1016/j.ebiom.2016.03.027
10.1002/sctm.17-0040
10.1371/journal.pone.0067939
10.1155/2017/8506370
10.1371/journal.pone.0012077
10.1155/2021/5556800
10.1016/j.jstrokecerebrovasdis.2014.06.011
10.1371/journal.pone.0176412
10.1002/ehf2.14281
10.2217/rme.12.17
10.1177/0963689719883592
10.1016/j.tice.2021.101504
10.4252/wjsc.v15.i2.16
10.1590/0102-672020190001e1465
10.1161/JAHA.119.015502
10.1016/j.tibtech.2006.01.010
10.4070/kcj.2016.0207
10.1161/CIRCRESAHA.117.310712
10.1002/ejhf.2772
10.1002/ccd.26601
10.1016/j.biopha.2020.110813
10.1161/01.CIR.0000114522.38265.61
10.1046/j.1445-2197.2003.02748.x
10.1016/j.ahj.2014.03.022
10.1016/j.jacc.2011.09.065
10.1186/1475-925X-13-54
10.1091/mbc.e02-02-0105
10.1016/j.jacc.2009.06.055
10.1089/scd.2010.0231
ContentType Journal Article
Copyright This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright_xml – notice: This work is licensed under a Creative Commons Attribution 4.0 International License.
DBID AAYXX
CITATION
GPN
DOA
DOI 10.36660/abc.20230830
DatabaseName CrossRef
SciELO
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
DatabaseTitleList
CrossRef

Database_xml – sequence: 1
  dbid: DOA
  name: Directory of Open Access Journals (DOAJ)
  url: https://www.doaj.org/
  sourceTypes: Open Website
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitleAlternate Safety and Efficacy of Adipose-Derived Mesenchymal Stem Cell Therapy for Ischemic Heart Disease: A Systematic Review
EISSN 1678-4170
ExternalDocumentID oai_doaj_org_article_4592fc85ab0b4a6fa439869da2e8e049
S0066_782X2024000900304
10_36660_abc_20230830
GroupedDBID 23N
2WC
53G
5GY
5VS
6J9
AAYXX
ABXHO
ACGFO
ADBBV
ADRAZ
AENEX
ALMA_UNASSIGNED_HOLDINGS
AOIJS
APOWU
AZFZN
BAWUL
BCNDV
C1A
CITATION
CS3
DIK
E3Z
EBS
EJD
F5P
GROUPED_DOAJ
GX1
HYE
IPNFZ
KQ8
M48
M~E
OK1
P2P
PGMZT
RIG
RNS
RPM
RSC
SCD
TR2
XSB
GPN
ID FETCH-LOGICAL-c1434-c19e9edddb99e315edaf9ca508d96a2778ec589dec8bd040ffc3a9c3db41fbda3
IEDL.DBID M48
ISSN 0066-782X
1678-4170
IngestDate Tue Oct 22 15:14:38 EDT 2024
Fri Oct 18 20:44:56 EDT 2024
Wed Oct 09 16:52:52 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 9
Keywords Medicina Regenerativa
Terapia Baseada em Transplante de Células e Tecidos
Isquemia Miocárdica
Células-Tronco Mesenquimais
Regenerative Medicine
Cell- and Tissue-Based Therapy
Myocardial Ischemia
Mesenchymal Stem Cells
Language Portuguese
English
License This work is licensed under a Creative Commons Attribution 4.0 International License. http://creativecommons.org/licenses/by/4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c1434-c19e9edddb99e315edaf9ca508d96a2778ec589dec8bd040ffc3a9c3db41fbda3
ORCID 0000-0001-9268-286X
0000-0003-2390-1605
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.36660/abc.20230830
ParticipantIDs doaj_primary_oai_doaj_org_article_4592fc85ab0b4a6fa439869da2e8e049
scielo_journals_S0066_782X2024000900304
crossref_primary_10_36660_abc_20230830
PublicationCentury 2000
PublicationDate 20240001
PublicationDateYYYYMMDD 2024-01-01
PublicationDate_xml – year: 2024
  text: 20240001
  day: 01
PublicationDecade 2020
PublicationTitle Arquivos brasileiros de cardiologia
PublicationTitleAlternate Arq. Bras. Cardiol
PublicationYear 2024
Publisher Sociedade Brasileira de Cardiologia - SBC
Sociedade Brasileira de Cardiologia (SBC)
Publisher_xml – name: Sociedade Brasileira de Cardiologia - SBC
– name: Sociedade Brasileira de Cardiologia (SBC)
References Slim K (ref29) 2003; 73
Gowdak LHW (ref50) 2023; 10
Qayyum AA (ref35) 2017; 2017
Karantalis V (ref53) 2014; 114
Danieli P (ref4) 2015; 4
Hare JM (ref52) 2009; 54
Henry TD (ref33) 2017; 89
Qayyum AA (ref37) 2019; 28
Perin EC (ref49) 2023; 81
Guyatt JB (ref27) 2021
Sterne JA (ref28) 2016; 355
Qayyum AA (ref46) 2023; 10
Qayyum AA (ref36) 2019; 17
Higgins JPT (ref25) 2019
Hur JW (ref15) 2016; 39
Qayyum AA (ref44) 2023; 25
Nakamuta JS (ref7) 2009; 4
Kastrup J (ref39) 2017; 6
Gonçalves GA (ref8) 2010; 17
Bayes-Genis A (ref31) 2016; 7
Joo HJ (ref20) 2017; 47
Danoviz ME (ref9) 2010; 5
Perin EC (ref38) 2014; 168
Fraser JK (ref17) 2006; 24
Szydlak R (ref48) 2023; 15
Bartolucci J (ref55) 2017; 121
Díez-Tejedor E (ref16) 2014; 23
Gentile P (ref12) 2021; 22
Hare JM (ref51) 2012; 308
Bunnell BA (ref11) 2008; 45
(ref24) 2012
Dariolli R (ref21) 2017; 12
Gao LR (ref54) 2015; 13
Danoviz ME (ref3) 2011; 20
Ma T (ref19) 2017; 8
Dariolli R (ref2) 2013; 8
Bernardi L (ref13) 2019; 32
Paitazoglou C (ref45) 2019; 21
Qayyum AA (ref34) 2012; 7
Hashemzadeh MR (ref6) 2021; 71
Kloner RA (ref47) 2020; 9
Thakkar UG (ref14) 2015; 17
Konstanty-Kalandyk J (ref43) 2021; 2021
Konstanty-Kalandyk J (ref42) 2018; 14
Zuk PA (ref10) 2002; 13
Povsic TJ (ref22) 2021; 14
Girão-Silva T (ref5) 2014; 13
Nasser MI (ref1) 2020; 132
Heidenreich PA (ref23) 2022; 145
Kastrup J (ref40) 2017; 2017
Planat-Benard V (ref18) 2004; 109
Konstanty-Kalandyk J (ref41) 2018; 76
Houtgraaf JH (ref32) 2012; 59
Moher D (ref26) 2009; 6
Popay J (ref30) 2006
Ma, T; Sun, J; Zhao, Z; Lei, W; Chen, Y; Wang, X 2017; 8
Perin, EC; Borow, KM; Henry, TD; Mendelsohn, FO; Miller, LW; Swiggum, E 2023; 81
Thakkar, UG; Trivedi, HL; Vanikar, AV; Dave, SD 2015; 17
Danoviz, ME; Bassaneze, V; Nakamuta, JS; Santos Junior, GR; Saint-Clair, D; Bajgelman, MC 2011; 20
Joo, HJ; Kim, JH; Hong, SJ 2017; 47
Qayyum, AA; Mathiasen, AB; Mygind, ND; Vejlstrup, NG; Kastrup, J 2019; 28
Girão-Silva, T; Bassaneze, V; Campos, LC; Barauna, VG; Dallan, LA; Krieger, JE 2014; 13
Hur, JW; Cho, TH; Park, DH; Lee, JB; Park, JY; Chung, YG 2016; 39
Qayyum, AA; Haack-Sørensen, M; Mathiasen, AB; Jørgensen, E; Ekblond, A; Kastrup, J 2012; 7
Danoviz, ME; Nakamuta, JS; Marques, FL; Santos, L; Alvarenga, EC; Santos, AA 2010; 5
Popay, J; Roberts, R; Sowden, A; Petticrew, M; Arai, L; Rodgers, M 2006
Bunnell, BA; Flaat, M; Gagliardi, C; Patel, B; Ripoll, C 2008; 45
Fraser, JK; Wulur, I; Alfonso, Z; Hedrick, MH 2006; 24
Zuk, PA; Zhu, M; Ashjian, P; De Ugarte, DA; Huang, JI; Mizuno, H 2002; 13
Paitazoglou, C; Bergmann, MW; Vrtovec, B; Chamuleau, SAJ; van Klarenbosch, B; Wojakowski, W 2019; 21
Dariolli, R; Bassaneze, V; Nakamuta, JS; Omae, SV; Campos, LC; Krieger, JE 2013; 8
Bayes-Genis, A; Gastelurrutia, P; Cámara, ML; Teis, A; Lupón, J; Llibre, C 2016; 7
Higgins, JPT; Chandler, J; Cumpston, M; Li, T; Page, MJ; Welch, VA 2019
Qayyum, AA; Mathiasen, AB; Mygind, ND; Kühl, JT; Jørgensen, E; Helqvist, S 2017; 2017
Gonçalves, GA; Vassallo, PF; Santos, L; Schettert, IT; Nakamuta, JS; Becker, C 2010; 17
Kastrup, J; Haack-Sørensen, M; Juhl, M; Søndergaard, RH; Follin, B; Lund, LD 2017; 6
Bartolucci, J; Verdugo, FJ; González, PL; Larrea, RE; Abarzua, E; Goset, C 2017; 121
Perin, EC; Sanz-Ruiz, R; Sánchez, PL; Lasso, J; Pérez-Cano, R; Alonso-Farto, JC 2014; 168
Kloner, RA 2020; 9
Konstanty-Kalandyk, J; Sadowski, J; Kedziora, A; Urbanczyk-Zawadzka, M; Baran, J; Banys, P 2021; 2021
Nakamuta, JS; Danoviz, ME; Marques, FL; Santos, L; Becker, C; Gonçalves, GA 2009; 4
Hare, JM; Traverse, JH; Henry, TD; Dib, N; Strumpf, RK; Schulman, SP 2009; 54
Hashemzadeh, MR; Yazdi, MET; Amiri, MS; Mousavi, SH 2021; 71
2012
Slim, K; Nini, E; Forestier, D; Kwiatkowski, F; Panis, Y; Chipponi, J 2003; 73
Sterne, JA; Hernán, MA; Reeves, BC; Savovic, J; Berkman, ND; Viswanathan, M 2016; 355
Planat-Benard, V; Silvestre, JS; Cousin, B; André, M; Nibbelink, M; Tamarat, R 2004; 109
Karantalis, V; Di Fede, DL; Gerstenblith, G; Pham, S; Symes, J; Zambrano, JP 2014; 114
Szydlak, R 2023; 15
Díez-Tejedor, E; Gutiérrez-Fernández, M; Martínez-Sánchez, P; Rodríguez-Frutos, B; Ruiz-Ares, G; Lara, ML 2014; 23
Guyatt, JB 2021
Dariolli, R; Naghetini, MV; Marques, EF; Takimura, CK; Jensen, LS; Kiers, B 2017; 12
Heidenreich, PA; Bozkurt, B; Aguilar, D; Allen, LA; Byun, JJ; Colvin, MM 2022; 145
Danieli, P; Malpasso, G; Ciuffreda, MC; Cervio, E; Calvillo, L; Copes, F 2015; 4
Konstanty-Kalandyk, J; Piatek, J; Chrapusta, A; Song, BH; Urbanczyk-Zawadzka, M; Slósarczyk, B 2018; 76
Bernardi, L; Santos, CHMD; Pinheiro, VAZ; Oliveira, RJ; Antoniolli-Silva, ACMB 2019; 32
Qayyum, AA; van Klarenbosch, B; Frljak, S; Cerar, A; Poglajen, G; Traxler-Weidenauer, D 2023; 25
Houtgraaf, JH; den Dekker, WK; van Dalen, BM; Springeling, T; de Jong, R; van Geuns, RJ 2012; 59
Gowdak, LHW; Schettert, IT; Rochitte, CE; Carvalho, LP; Vieira, MLC; Dallan, LAO 2023; 10
Kastrup, J; Schou, M; Gustafsson, I; Nielsen, OW; Møgelvang, R; Kofoed, KF 2017; 2017
Henry, TD; Pepine, CJ; Lambert, CR; Traverse, JH; Schatz, R; Costa, M 2017; 89
Konstanty-Kalandyk, J; Bartus, K; Piatek, J; Vuddanda, V; Lee, R; Kedziora, A 2018; 14
Qayyum, AA; Mouridsen, M; Nilsson, B; Gustafsson, I; Schou, M; Nielsen, OW 2023; 10
Moher, D; Liberati, A; Tetzlaff, J; Altman, DG 2009; 6
Gao, LR; Chen, Y; Zhang, NK; Yang, XL; Liu, HL; Wang, ZG 2015; 13
Nasser, MI; Qi, X; Zhu, S; He, Y; Zhao, M; Guo, H 2020; 132
Gentile, P; Garcovich, S 2021; 22
Hare, JM; Fishman, JE; Gerstenblith, G; Velazquez, DL; Zambrano, JP; Suncion, VY 2012; 308
Povsic, TJ; Henry, TD; Ohman, EM 2021; 14
Qayyum, AA; Mathiasen, AB; Helqvist, S; Jørgensen, E; Haack-Sørensen, M; Ekblond, A 2019; 17
References_xml – volume: 14
  issue: 2
  year: 2021
  ident: ref22
  article-title: Therapeutic Approaches for the No-Option Refractory Angina Patient
  publication-title: Circ Cardiovasc Interv
  doi: 10.1161/CIRCINTERVENTIONS.120.009002
  contributor:
    fullname: Povsic TJ
– volume: 81
  start-page: 849
  issue: 9
  year: 2023
  ident: ref49
  article-title: Randomized Trial of Targeted Transendocardial Mesenchymal Precursor Cell Therapy in Patients with Heart Failure
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2022.11.061
  contributor:
    fullname: Perin EC
– volume: 17
  issue: 1
  year: 2019
  ident: ref36
  article-title: Autologous Adipose-derived Stromal Cell Treatment for Patients with Refractory Angina (MyStromalCell Trial): 3-years Follow-up Results
  publication-title: J Transl Med
  doi: 10.1186/s12967-019-2110-1
  contributor:
    fullname: Qayyum AA
– volume: 10
  year: 2023
  ident: ref50
  article-title: Additional Improvement in Regional Myocardial Ischemia After Intracardiac Injection of Bone Marrow Cells During CABG Surgery
  publication-title: Front Cardiovasc Med
  contributor:
    fullname: Gowdak LHW
– volume: 145
  start-page: 895
  issue: 18
  year: 2022
  ident: ref23
  article-title: 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
  publication-title: Circulation
  contributor:
    fullname: Heidenreich PA
– volume: 308
  start-page: 2369
  issue: 22
  year: 2012
  ident: ref51
  article-title: Comparison of Allogeneic vs Autologous Bone Marrow-derived Mesenchymal Stem Cells Delivered by Transendocardial Injection in Patients with Ischemic Cardiomyopathy: The POSEIDON Randomized Trial
  publication-title: JAMA
  doi: 10.1001/jama.2012.25321
  contributor:
    fullname: Hare JM
– volume: 8
  issue: 1
  year: 2017
  ident: ref19
  article-title: A Brief Review: Adipose-derived Stem Cells and Their Therapeutic Potential in Cardiovascular Diseases
  publication-title: Stem Cell Res Ther
  contributor:
    fullname: Ma T
– volume: 39
  start-page: 655
  issue: 6
  year: 2016
  ident: ref15
  article-title: Intrathecal Transplantation of Autologous Adipose-derived Mesenchymal Stem Cells for Treating Spinal Cord Injury: A Human Trial
  publication-title: J Spinal Cord Med
  doi: 10.1179/2045772315Y.0000000048
  contributor:
    fullname: Hur JW
– volume: 2017
  year: 2017
  ident: ref35
  article-title: Adipose-Derived Stromal Cells for Treatment of Patients with Chronic Ischemic Heart Disease (MyStromalCell Trial): A Randomized Placebo-Controlled Study
  publication-title: Stem Cells Int
  doi: 10.1155/2017/5237063
  contributor:
    fullname: Qayyum AA
– year: 2012
  ident: ref24
– volume: 76
  start-page: 911
  issue: 5
  year: 2018
  ident: ref41
  article-title: Use of Adipose-derived Stromal Cells in the Treatment of Chronic Ischaemic Heart Disease: Safety and Feasibility Study
  publication-title: Kardiol Pol
  doi: 10.5603/KP.2018.0097
  contributor:
    fullname: Konstanty-Kalandyk J
– volume: 6
  issue: 7
  year: 2009
  ident: ref26
  article-title: Preferred Reporting Items for Systematic Reviews and Meta-analyses: The PRISMA Statement
  publication-title: PLoS Med
  doi: 10.1371/journal.pmed.1000097
  contributor:
    fullname: Moher D
– volume: 114
  start-page: 1302
  issue: 8
  year: 2014
  ident: ref53
  article-title: Autologous Mesenchymal Stem Cells Produce Concordant Improvements in Regional Function, Tissue Perfusion, and Fibrotic Burden when Administered to Patients Undergoing Coronary Artery Bypass Grafting: The Prospective Randomized Study of Mesenchymal Stem Cell Therapy in Patients Undergoing Cardiac Surgery (PROMETHEUS) Trial
  publication-title: Circ Res
  doi: 10.1161/CIRCRESAHA.114.303180
  contributor:
    fullname: Karantalis V
– volume: 21
  start-page: 1032
  issue: 8
  year: 2019
  ident: ref45
  article-title: Rationale and Design of the European Multicentre Study on Stem Cell therapy in IschEmic Non-treatable Cardiac diseasE (SCIENCE)
  publication-title: Eur J Heart Fail
  doi: 10.1002/ejhf.1412
  contributor:
    fullname: Paitazoglou C
– volume: 355
  year: 2016
  ident: ref28
  article-title: ROBINS-I: A Tool for Assessing Risk of Bias in Non-randomised Studies of Interventions
  publication-title: BMJ
  contributor:
    fullname: Sterne JA
– volume: 45
  start-page: 115
  issue: 2
  year: 2008
  ident: ref11
  article-title: Adipose-derived Stem Cells: Isolation, Expansion and Differentiation
  publication-title: Methods
  doi: 10.1016/j.ymeth.2008.03.006
  contributor:
    fullname: Bunnell BA
– volume: 22
  start-page: 1538
  issue: 4
  year: 2021
  ident: ref12
  article-title: Systematic Review: Adipose-Derived Mesenchymal Stem Cells, Platelet-Rich Plasma and Biomaterials as New Regenerative Strategies in Chronic Skin Wounds and Soft Tissue Defects
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms22041538
  contributor:
    fullname: Gentile P
– volume: 17
  start-page: 305
  issue: 3
  year: 2010
  ident: ref8
  article-title: Intramyocardial Transplantation of Fibroblasts Expressing Vascular Endothelial Growth Factor Attenuates Cardiac Dysfunction
  publication-title: Gene Ther
  doi: 10.1038/gt.2009.146
  contributor:
    fullname: Gonçalves GA
– volume: 4
  start-page: 448
  issue: 5
  year: 2015
  ident: ref4
  article-title: Conditioned Medium from Human Amniotic Mesenchymal Stromal Cells Limits Infarct Size and Enhances Angiogenesis
  publication-title: Stem Cells Transl Med
  doi: 10.5966/sctm.2014-0253
  contributor:
    fullname: Danieli P
– volume: 4
  start-page: e6005
  issue: 6
  year: 2009
  ident: ref7
  article-title: Cell Therapy Attenuates Cardiac Dysfunction Post Myocardial Infarction: Effect of Timing, Routes of Injection and a Fibrin Scaffold
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0006005
  contributor:
    fullname: Nakamuta JS
– volume: 17
  start-page: 940
  issue: 7
  year: 2015
  ident: ref14
  article-title: Insulin-secreting Adipose-derived Mesenchymal Stromal Cells with Bone Marrow-derived Hematopoietic Stem Cells from Autologous and Allogenic Sources for Type 1 Diabetes Mellitus
  publication-title: Cytotherapy
  doi: 10.1016/j.jcyt.2015.03.608
  contributor:
    fullname: Thakkar UG
– volume: 7
  start-page: 248
  year: 2016
  ident: ref31
  article-title: First-in-man Safety and Efficacy of the Adipose Graft Transposition Procedure (AGTP) in Patients with a Myocardial Scar
  publication-title: EBioMedicine
  doi: 10.1016/j.ebiom.2016.03.027
  contributor:
    fullname: Bayes-Genis A
– volume: 6
  start-page: 1963
  issue: 11
  year: 2017
  ident: ref39
  article-title: Cryopreserved Off-the-Shelf Allogeneic Adipose-Derived Stromal Cells for Therapy in Patients with Ischemic Heart Disease and Heart Failure-A Safety Study
  publication-title: Stem Cells Transl Med
  doi: 10.1002/sctm.17-0040
  contributor:
    fullname: Kastrup J
– volume: 8
  issue: 7
  year: 2013
  ident: ref2
  article-title: Porcine Adipose Tissue-derived Mesenchymal Stem Cells Retain Their Proliferative Characteristics, Senescence, Karyotype and Plasticity After Long-term Cryopreservation
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0067939
  contributor:
    fullname: Dariolli R
– volume: 2017
  year: 2017
  ident: ref40
  article-title: Rationale and Design of the First Double-Blind, Placebo-Controlled Trial with Allogeneic Adipose Tissue-Derived Stromal Cell Therapy in Patients with Ischemic Heart Failure: A Phase II Danish Multicentre Study
  publication-title: Stem Cells Int
  doi: 10.1155/2017/8506370
  contributor:
    fullname: Kastrup J
– volume: 5
  issue: 8
  year: 2010
  ident: ref9
  article-title: Rat Adipose Tissue-derived Stem Cells Transplantation Attenuates Cardiac Dysfunction Post Infarction and Biopolymers Enhance Cell Retention
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0012077
  contributor:
    fullname: Danoviz ME
– volume: 14
  start-page: 176
  issue: 2
  year: 2018
  ident: ref42
  article-title: Midterm Outcomes of Transmyocardial Laser Revascularization with Intramyocardial Injection of Adipose Derived Stromal Cells for Severe Refractory Angina
  publication-title: Postepy Kardiol Interwencyjnej
  contributor:
    fullname: Konstanty-Kalandyk J
– volume: 2021
  year: 2021
  ident: ref43
  article-title: Functional Recovery after Intramyocardial Injection of Adipose-Derived Stromal Cells Assessed by Cardiac Magnetic Resonance Imaging
  publication-title: Stem Cells Int
  doi: 10.1155/2021/5556800
  contributor:
    fullname: Konstanty-Kalandyk J
– year: 2021
  ident: ref27
  contributor:
    fullname: Guyatt JB
– volume: 23
  start-page: 2694
  issue: 10
  year: 2014
  ident: ref16
  article-title: Reparative Therapy for Acute Ischemic Stroke with Allogeneic Mesenchymal Stem Cells from Adipose Tissue: A Safety Assessment: A Phase II Randomized, Double-blind, Placebo-controlled, Single-center, Pilot Clinical Trial
  publication-title: J Stroke Cerebrovasc Dis
  doi: 10.1016/j.jstrokecerebrovasdis.2014.06.011
  contributor:
    fullname: Díez-Tejedor E
– year: 2019
  ident: ref25
  contributor:
    fullname: Higgins JPT
– volume: 12
  issue: 4
  year: 2017
  ident: ref21
  article-title: Allogeneic pASC Transplantation in Humanized Pigs Attenuates Cardiac Remodeling Post-myocardial Infarction
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0176412
  contributor:
    fullname: Dariolli R
– volume: 10
  start-page: 1170
  issue: 2
  year: 2023
  ident: ref46
  article-title: Danish Phase II Trial Using Adipose Tissue Derived Mesenchymal Stromal Cells for Patients with Ischaemic Heart Failure
  publication-title: ESC Heart Fail
  doi: 10.1002/ehf2.14281
  contributor:
    fullname: Qayyum AA
– volume: 7
  start-page: 421
  issue: 3
  year: 2012
  ident: ref34
  article-title: Adipose-derived Mesenchymal Stromal Cells for Chronic Myocardial Ischemia (MyStromalCell Trial): Study Design
  publication-title: Regen Med
  doi: 10.2217/rme.12.17
  contributor:
    fullname: Qayyum AA
– volume: 28
  start-page: 1700
  issue: 12
  year: 2019
  ident: ref37
  article-title: Cardiac Magnetic Resonance Imaging used for Evaluation of Adipose-Derived Stromal Cell Therapy in Patients with Chronic Ischemic Heart Disease
  publication-title: Cell Transplant
  doi: 10.1177/0963689719883592
  contributor:
    fullname: Qayyum AA
– year: 2006
  ident: ref30
  contributor:
    fullname: Popay J
– volume: 71
  year: 2021
  ident: ref6
  article-title: Stem Cell Therapy in the Heart: Biomaterials as a Key Route
  publication-title: Tissue Cell
  doi: 10.1016/j.tice.2021.101504
  contributor:
    fullname: Hashemzadeh MR
– volume: 15
  start-page: 16
  issue: 2
  year: 2023
  ident: ref48
  article-title: Mesenchymal Stem Cells in Ischemic Tissue Regeneration
  publication-title: World J Stem Cells
  doi: 10.4252/wjsc.v15.i2.16
  contributor:
    fullname: Szydlak R
– volume: 32
  issue: 4
  year: 2019
  ident: ref13
  article-title: Transplantation of Adipose-derived Mesenchymal Stem Cells in Refractory Crohn's Disease: Systematic Review
  publication-title: Arq Bras Cir Dig
  doi: 10.1590/0102-672020190001e1465
  contributor:
    fullname: Bernardi L
– volume: 9
  issue: 3
  year: 2020
  ident: ref47
  article-title: Stunned and Hibernating Myocardium: Where Are We Nearly 4 Decades Later?
  publication-title: J Am Heart Assoc
  doi: 10.1161/JAHA.119.015502
  contributor:
    fullname: Kloner RA
– volume: 24
  start-page: 150
  issue: 4
  year: 2006
  ident: ref17
  article-title: Fat Tissue: An Underappreciated Source of Stem Cells for Biotechnology
  publication-title: Trends Biotechnol
  doi: 10.1016/j.tibtech.2006.01.010
  contributor:
    fullname: Fraser JK
– volume: 47
  start-page: 151
  issue: 2
  year: 2017
  ident: ref20
  article-title: Adipose Tissue-Derived Stem Cells for Myocardial Regeneration
  publication-title: Korean Circ J
  doi: 10.4070/kcj.2016.0207
  contributor:
    fullname: Joo HJ
– volume: 121
  start-page: 1192
  issue: 10
  year: 2017
  ident: ref55
  article-title: Safety and Efficacy of the Intravenous Infusion of Umbilical Cord Mesenchymal Stem Cells in Patients with Heart Failure: A Phase 1/2 Randomized Controlled Trial (RIMECARD Trial [Randomized Clinical Trial of Intravenous Infusion Umbilical Cord Mesenchymal Stem Cells on Cardiopathy])
  publication-title: Circ Res
  doi: 10.1161/CIRCRESAHA.117.310712
  contributor:
    fullname: Bartolucci J
– volume: 25
  start-page: 576
  issue: 4
  year: 2023
  ident: ref44
  article-title: Effect of Allogeneic Adipose Tissue-derived Mesenchymal Stromal Cell Treatment in Chronic Ischaemic Heart Failure with Reduced Ejection Fraction - The SCIENCE Trial
  publication-title: Eur J Heart Fail
  doi: 10.1002/ejhf.2772
  contributor:
    fullname: Qayyum AA
– volume: 89
  start-page: 169
  issue: 2
  year: 2017
  ident: ref33
  article-title: The Athena Trials: Autologous Adipose-derived Regenerative Cells for Refractory Chronic Myocardial Ischemia with Left Ventricular Dysfunction
  publication-title: Catheter Cardiovasc Interv
  doi: 10.1002/ccd.26601
  contributor:
    fullname: Henry TD
– volume: 132
  year: 2020
  ident: ref1
  article-title: Current Situation and Future of Stem Cells in Cardiovascular Medicine
  publication-title: Biomed Pharmacother
  doi: 10.1016/j.biopha.2020.110813
  contributor:
    fullname: Nasser MI
– volume: 109
  start-page: 656
  issue: 5
  year: 2004
  ident: ref18
  article-title: Plasticity of Human Adipose Lineage Cells Toward Endothelial Cells: Physiological and Therapeutic Perspectives
  publication-title: Circulation
  doi: 10.1161/01.CIR.0000114522.38265.61
  contributor:
    fullname: Planat-Benard V
– volume: 73
  start-page: 712
  issue: 9
  year: 2003
  ident: ref29
  article-title: Methodological Index for Non-randomized Studies (Minors): Development and Validation of a New Instrument
  publication-title: ANZ J Surg
  doi: 10.1046/j.1445-2197.2003.02748.x
  contributor:
    fullname: Slim K
– volume: 168
  start-page: 88
  issue: 1
  year: 2014
  ident: ref38
  article-title: Adipose-derived Regenerative Cells in Patients with Ischemic Cardiomyopathy: The PRECISE Trial
  publication-title: Am Heart J
  doi: 10.1016/j.ahj.2014.03.022
  contributor:
    fullname: Perin EC
– volume: 59
  start-page: 539
  issue: 5
  year: 2012
  ident: ref32
  article-title: First Experience in Humans Using Adipose Tissue-derived Regenerative Cells in the Treatment of Patients with ST-segment Elevation Myocardial Infarction
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2011.09.065
  contributor:
    fullname: Houtgraaf JH
– volume: 13
  year: 2014
  ident: ref5
  article-title: Short-term mechanical stretch Fails To Differentiate Human Adipose-Derived Stem Cells Into Cardiovascular Cell Phenotypes
  publication-title: Biomed Eng Online
  doi: 10.1186/1475-925X-13-54
  contributor:
    fullname: Girão-Silva T
– volume: 13
  start-page: 4279
  issue: 12
  year: 2002
  ident: ref10
  article-title: Human Adipose Tissue is a Source of Multipotent Stem Cells
  publication-title: Mol Biol Cell
  doi: 10.1091/mbc.e02-02-0105
  contributor:
    fullname: Zuk PA
– volume: 13
  year: 2015
  ident: ref54
  article-title: Intracoronary Infusion of Wharton's Jelly-derived Mesenchymal Stem Cells in Acute Myocardial Infarction: Double-blind, Randomized Controlled Trial
  publication-title: BMC Med
  contributor:
    fullname: Gao LR
– volume: 54
  start-page: 2277
  issue: 24
  year: 2009
  ident: ref52
  article-title: A Randomized, Double-blind, Placebo-controlled, Dose-escalation Study of Intravenous Adult Human Mesenchymal Stem Cells (Prochymal) After Acute Myocardial Infarction
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2009.06.055
  contributor:
    fullname: Hare JM
– volume: 20
  start-page: 661
  issue: 4
  year: 2011
  ident: ref3
  article-title: Adipose Tissue-derived Stem Cells from Humans and Mice Differ in Proliferative Capacity and Genome Stability in Long-term Cultures
  publication-title: Stem Cells Dev
  doi: 10.1089/scd.2010.0231
  contributor:
    fullname: Danoviz ME
– volume: 5
  issue: 8
  year: 2010
  article-title: Rat Adipose Tissue-derived Stem Cells Transplantation Attenuates Cardiac Dysfunction Post Infarction and Biopolymers Enhance Cell Retention
  publication-title: PLoS One
  contributor:
    fullname: Danoviz, ME; Nakamuta, JS; Marques, FL; Santos, L; Alvarenga, EC; Santos, AA
– volume: 13
  start-page: 4279
  issue: 12
  year: 2002
  end-page: 4295
  article-title: Human Adipose Tissue is a Source of Multipotent Stem Cells
  publication-title: Mol Biol Cell
  contributor:
    fullname: Zuk, PA; Zhu, M; Ashjian, P; De Ugarte, DA; Huang, JI; Mizuno, H
– volume: 10
  year: 2023
  article-title: Additional Improvement in Regional Myocardial Ischemia After Intracardiac Injection of Bone Marrow Cells During CABG Surgery
  publication-title: Front Cardiovasc Med
  contributor:
    fullname: Gowdak, LHW; Schettert, IT; Rochitte, CE; Carvalho, LP; Vieira, MLC; Dallan, LAO
– year: 2021
  publication-title: Methods Commentary: Risk of Bias in Randomized Trials 1: The Clarity Group and Evidence Partners
  contributor:
    fullname: Guyatt, JB
– volume: 13
  year: 2014
  article-title: Short-term mechanical stretch Fails To Differentiate Human Adipose-Derived Stem Cells Into Cardiovascular Cell Phenotypes
  publication-title: Biomed Eng Online
  contributor:
    fullname: Girão-Silva, T; Bassaneze, V; Campos, LC; Barauna, VG; Dallan, LA; Krieger, JE
– volume: 132
  year: 2020
  article-title: Current Situation and Future of Stem Cells in Cardiovascular Medicine
  publication-title: Biomed Pharmacother
  contributor:
    fullname: Nasser, MI; Qi, X; Zhu, S; He, Y; Zhao, M; Guo, H
– volume: 8
  issue: 1
  year: 2017
  article-title: A Brief Review: Adipose-derived Stem Cells and Their Therapeutic Potential in Cardiovascular Diseases
  publication-title: Stem Cell Res Ther
  contributor:
    fullname: Ma, T; Sun, J; Zhao, Z; Lei, W; Chen, Y; Wang, X
– volume: 45
  start-page: 115
  issue: 2
  year: 2008
  end-page: 120
  article-title: Adipose-derived Stem Cells: Isolation, Expansion and Differentiation
  publication-title: Methods
  contributor:
    fullname: Bunnell, BA; Flaat, M; Gagliardi, C; Patel, B; Ripoll, C
– volume: 2017
  year: 2017
  article-title: Rationale and Design of the First Double-Blind, Placebo-Controlled Trial with Allogeneic Adipose Tissue-Derived Stromal Cell Therapy in Patients with Ischemic Heart Failure: A Phase II Danish Multicentre Study
  publication-title: Stem Cells Int
  contributor:
    fullname: Kastrup, J; Schou, M; Gustafsson, I; Nielsen, OW; Møgelvang, R; Kofoed, KF
– year: 2019
  publication-title: Cochrane Handbook for Systematic Reviews of Interventions
  contributor:
    fullname: Higgins, JPT; Chandler, J; Cumpston, M; Li, T; Page, MJ; Welch, VA
– volume: 15
  start-page: 16
  issue: 2
  year: 2023
  end-page: 30
  article-title: Mesenchymal Stem Cells in Ischemic Tissue Regeneration
  publication-title: World J Stem Cells
  contributor:
    fullname: Szydlak, R
– volume: 76
  start-page: 911
  issue: 5
  year: 2018
  end-page: 913
  article-title: Use of Adipose-derived Stromal Cells in the Treatment of Chronic Ischaemic Heart Disease: Safety and Feasibility Study
  publication-title: Kardiol Pol
  contributor:
    fullname: Konstanty-Kalandyk, J; Piatek, J; Chrapusta, A; Song, BH; Urbanczyk-Zawadzka, M; Slósarczyk, B
– volume: 9
  issue: 3
  year: 2020
  article-title: Stunned and Hibernating Myocardium: Where Are We Nearly 4 Decades Later?
  publication-title: J Am Heart Assoc
  contributor:
    fullname: Kloner, RA
– volume: 109
  start-page: 656
  issue: 5
  year: 2004
  end-page: 663
  article-title: Plasticity of Human Adipose Lineage Cells Toward Endothelial Cells: Physiological and Therapeutic Perspectives
  publication-title: Circulation
  contributor:
    fullname: Planat-Benard, V; Silvestre, JS; Cousin, B; André, M; Nibbelink, M; Tamarat, R
– volume: 14
  start-page: 176
  issue: 2
  year: 2018
  end-page: 182
  article-title: Midterm Outcomes of Transmyocardial Laser Revascularization with Intramyocardial Injection of Adipose Derived Stromal Cells for Severe Refractory Angina
  publication-title: Postepy Kardiol Interwencyjnej
  contributor:
    fullname: Konstanty-Kalandyk, J; Bartus, K; Piatek, J; Vuddanda, V; Lee, R; Kedziora, A
– volume: 23
  start-page: 2694
  issue: 10
  year: 2014
  end-page: 2700
  article-title: Reparative Therapy for Acute Ischemic Stroke with Allogeneic Mesenchymal Stem Cells from Adipose Tissue: A Safety Assessment: A Phase II Randomized, Double-blind, Placebo-controlled, Single-center, Pilot Clinical Trial
  publication-title: J Stroke Cerebrovasc Dis
  contributor:
    fullname: Díez-Tejedor, E; Gutiérrez-Fernández, M; Martínez-Sánchez, P; Rodríguez-Frutos, B; Ruiz-Ares, G; Lara, ML
– volume: 17
  issue: 1
  year: 2019
  article-title: Autologous Adipose-derived Stromal Cell Treatment for Patients with Refractory Angina (MyStromalCell Trial): 3-years Follow-up Results
  publication-title: J Transl Med
  contributor:
    fullname: Qayyum, AA; Mathiasen, AB; Helqvist, S; Jørgensen, E; Haack-Sørensen, M; Ekblond, A
– volume: 145
  start-page: 895
  issue: 18
  year: 2022
  end-page: 1032
  article-title: 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
  publication-title: Circulation
  contributor:
    fullname: Heidenreich, PA; Bozkurt, B; Aguilar, D; Allen, LA; Byun, JJ; Colvin, MM
– volume: 17
  start-page: 940
  issue: 7
  year: 2015
  end-page: 947
  article-title: Insulin-secreting Adipose-derived Mesenchymal Stromal Cells with Bone Marrow-derived Hematopoietic Stem Cells from Autologous and Allogenic Sources for Type 1 Diabetes Mellitus
  publication-title: Cytotherapy
  contributor:
    fullname: Thakkar, UG; Trivedi, HL; Vanikar, AV; Dave, SD
– volume: 6
  issue: 7
  year: 2009
  article-title: Preferred Reporting Items for Systematic Reviews and Meta-analyses: The PRISMA Statement
  publication-title: PLoS Med
  contributor:
    fullname: Moher, D; Liberati, A; Tetzlaff, J; Altman, DG
– volume: 7
  start-page: 421
  issue: 3
  year: 2012
  end-page: 428
  article-title: Adipose-derived Mesenchymal Stromal Cells for Chronic Myocardial Ischemia (MyStromalCell Trial): Study Design
  publication-title: Regen Med
  contributor:
    fullname: Qayyum, AA; Haack-Sørensen, M; Mathiasen, AB; Jørgensen, E; Ekblond, A; Kastrup, J
– volume: 89
  start-page: 169
  issue: 2
  year: 2017
  end-page: 177
  article-title: The Athena Trials: Autologous Adipose-derived Regenerative Cells for Refractory Chronic Myocardial Ischemia with Left Ventricular Dysfunction
  publication-title: Catheter Cardiovasc Interv
  contributor:
    fullname: Henry, TD; Pepine, CJ; Lambert, CR; Traverse, JH; Schatz, R; Costa, M
– volume: 114
  start-page: 1302
  issue: 8
  year: 2014
  end-page: 1310
  article-title: Autologous Mesenchymal Stem Cells Produce Concordant Improvements in Regional Function, Tissue Perfusion, and Fibrotic Burden when Administered to Patients Undergoing Coronary Artery Bypass Grafting: The Prospective Randomized Study of Mesenchymal Stem Cell Therapy in Patients Undergoing Cardiac Surgery (PROMETHEUS) Trial
  publication-title: Circ Res
  contributor:
    fullname: Karantalis, V; Di Fede, DL; Gerstenblith, G; Pham, S; Symes, J; Zambrano, JP
– volume: 14
  issue: 2
  year: 2021
  article-title: Therapeutic Approaches for the No-Option Refractory Angina Patient
  publication-title: Circ Cardiovasc Interv
  contributor:
    fullname: Povsic, TJ; Henry, TD; Ohman, EM
– volume: 4
  start-page: e6005
  issue: 6
  year: 2009
  article-title: Cell Therapy Attenuates Cardiac Dysfunction Post Myocardial Infarction: Effect of Timing, Routes of Injection and a Fibrin Scaffold
  publication-title: PLoS One
  contributor:
    fullname: Nakamuta, JS; Danoviz, ME; Marques, FL; Santos, L; Becker, C; Gonçalves, GA
– volume: 81
  start-page: 849
  issue: 9
  year: 2023
  end-page: 863
  article-title: Randomized Trial of Targeted Transendocardial Mesenchymal Precursor Cell Therapy in Patients with Heart Failure
  publication-title: J Am Coll Cardiol
  contributor:
    fullname: Perin, EC; Borow, KM; Henry, TD; Mendelsohn, FO; Miller, LW; Swiggum, E
– volume: 2017
  year: 2017
  article-title: Adipose-Derived Stromal Cells for Treatment of Patients with Chronic Ischemic Heart Disease (MyStromalCell Trial): A Randomized Placebo-Controlled Study
  publication-title: Stem Cells Int
  contributor:
    fullname: Qayyum, AA; Mathiasen, AB; Mygind, ND; Kühl, JT; Jørgensen, E; Helqvist, S
– volume: 25
  start-page: 576
  issue: 4
  year: 2023
  end-page: 587
  article-title: Effect of Allogeneic Adipose Tissue-derived Mesenchymal Stromal Cell Treatment in Chronic Ischaemic Heart Failure with Reduced Ejection Fraction - The SCIENCE Trial
  publication-title: Eur J Heart Fail
  contributor:
    fullname: Qayyum, AA; van Klarenbosch, B; Frljak, S; Cerar, A; Poglajen, G; Traxler-Weidenauer, D
– volume: 6
  start-page: 1963
  issue: 11
  year: 2017
  end-page: 1971
  article-title: Cryopreserved Off-the-Shelf Allogeneic Adipose-Derived Stromal Cells for Therapy in Patients with Ischemic Heart Disease and Heart Failure-A Safety Study
  publication-title: Stem Cells Transl Med
  contributor:
    fullname: Kastrup, J; Haack-Sørensen, M; Juhl, M; Søndergaard, RH; Follin, B; Lund, LD
– volume: 71
  year: 2021
  article-title: Stem Cell Therapy in the Heart: Biomaterials as a Key Route
  publication-title: Tissue Cell
  contributor:
    fullname: Hashemzadeh, MR; Yazdi, MET; Amiri, MS; Mousavi, SH
– volume: 13
  year: 2015
  article-title: Intracoronary Infusion of Wharton's Jelly-derived Mesenchymal Stem Cells in Acute Myocardial Infarction: Double-blind, Randomized Controlled Trial
  publication-title: BMC Med
  contributor:
    fullname: Gao, LR; Chen, Y; Zhang, NK; Yang, XL; Liu, HL; Wang, ZG
– volume: 47
  start-page: 151
  issue: 2
  year: 2017
  end-page: 159
  article-title: Adipose Tissue-Derived Stem Cells for Myocardial Regeneration
  publication-title: Korean Circ J
  contributor:
    fullname: Joo, HJ; Kim, JH; Hong, SJ
– volume: 59
  start-page: 539
  issue: 5
  year: 2012
  end-page: 540
  article-title: First Experience in Humans Using Adipose Tissue-derived Regenerative Cells in the Treatment of Patients with ST-segment Elevation Myocardial Infarction
  publication-title: J Am Coll Cardiol
  contributor:
    fullname: Houtgraaf, JH; den Dekker, WK; van Dalen, BM; Springeling, T; de Jong, R; van Geuns, RJ
– volume: 73
  start-page: 712
  issue: 9
  year: 2003
  end-page: 716
  article-title: Methodological Index for Non-randomized Studies (Minors): Development and Validation of a New Instrument
  publication-title: ANZ J Surg
  contributor:
    fullname: Slim, K; Nini, E; Forestier, D; Kwiatkowski, F; Panis, Y; Chipponi, J
– volume: 2021
  year: 2021
  article-title: Functional Recovery after Intramyocardial Injection of Adipose-Derived Stromal Cells Assessed by Cardiac Magnetic Resonance Imaging
  publication-title: Stem Cells Int
  contributor:
    fullname: Konstanty-Kalandyk, J; Sadowski, J; Kedziora, A; Urbanczyk-Zawadzka, M; Baran, J; Banys, P
– volume: 10
  start-page: 1170
  issue: 2
  year: 2023
  end-page: 1183
  article-title: Danish Phase II Trial Using Adipose Tissue Derived Mesenchymal Stromal Cells for Patients with Ischaemic Heart Failure
  publication-title: ESC Heart Fail
  contributor:
    fullname: Qayyum, AA; Mouridsen, M; Nilsson, B; Gustafsson, I; Schou, M; Nielsen, OW
– volume: 4
  start-page: 448
  issue: 5
  year: 2015
  end-page: 458
  article-title: Conditioned Medium from Human Amniotic Mesenchymal Stromal Cells Limits Infarct Size and Enhances Angiogenesis
  publication-title: Stem Cells Transl Med
  contributor:
    fullname: Danieli, P; Malpasso, G; Ciuffreda, MC; Cervio, E; Calvillo, L; Copes, F
– volume: 121
  start-page: 1192
  issue: 10
  year: 2017
  end-page: 1204
  article-title: Safety and Efficacy of the Intravenous Infusion of Umbilical Cord Mesenchymal Stem Cells in Patients with Heart Failure: A Phase 1/2 Randomized Controlled Trial (RIMECARD Trial [Randomized Clinical Trial of Intravenous Infusion Umbilical Cord Mesenchymal Stem Cells on Cardiopathy])
  publication-title: Circ Res
  contributor:
    fullname: Bartolucci, J; Verdugo, FJ; González, PL; Larrea, RE; Abarzua, E; Goset, C
– volume: 168
  start-page: 88
  issue: 1
  year: 2014
  end-page: 95
  article-title: Adipose-derived Regenerative Cells in Patients with Ischemic Cardiomyopathy: The PRECISE Trial
  publication-title: Am Heart J
  contributor:
    fullname: Perin, EC; Sanz-Ruiz, R; Sánchez, PL; Lasso, J; Pérez-Cano, R; Alonso-Farto, JC
– volume: 39
  start-page: 655
  issue: 6
  year: 2016
  end-page: 664
  article-title: Intrathecal Transplantation of Autologous Adipose-derived Mesenchymal Stem Cells for Treating Spinal Cord Injury: A Human Trial
  publication-title: J Spinal Cord Med
  contributor:
    fullname: Hur, JW; Cho, TH; Park, DH; Lee, JB; Park, JY; Chung, YG
– volume: 24
  start-page: 150
  issue: 4
  year: 2006
  end-page: 154
  article-title: Fat Tissue: An Underappreciated Source of Stem Cells for Biotechnology
  publication-title: Trends Biotechnol
  contributor:
    fullname: Fraser, JK; Wulur, I; Alfonso, Z; Hedrick, MH
– volume: 7
  start-page: 248
  year: 2016
  end-page: 254
  article-title: First-in-man Safety and Efficacy of the Adipose Graft Transposition Procedure (AGTP) in Patients with a Myocardial Scar
  publication-title: EBioMedicine
  contributor:
    fullname: Bayes-Genis, A; Gastelurrutia, P; Cámara, ML; Teis, A; Lupón, J; Llibre, C
– volume: 308
  start-page: 2369
  issue: 22
  year: 2012
  end-page: 2379
  article-title: Comparison of Allogeneic vs Autologous Bone Marrow-derived Mesenchymal Stem Cells Delivered by Transendocardial Injection in Patients with Ischemic Cardiomyopathy: The POSEIDON Randomized Trial
  publication-title: JAMA
  contributor:
    fullname: Hare, JM; Fishman, JE; Gerstenblith, G; Velazquez, DL; Zambrano, JP; Suncion, VY
– volume: 355
  year: 2016
  article-title: ROBINS-I: A Tool for Assessing Risk of Bias in Non-randomised Studies of Interventions
  publication-title: BMJ
  contributor:
    fullname: Sterne, JA; Hernán, MA; Reeves, BC; Savovic, J; Berkman, ND; Viswanathan, M
– volume: 12
  issue: 4
  year: 2017
  article-title: Allogeneic pASC Transplantation in Humanized Pigs Attenuates Cardiac Remodeling Post-myocardial Infarction
  publication-title: PLoS One
  contributor:
    fullname: Dariolli, R; Naghetini, MV; Marques, EF; Takimura, CK; Jensen, LS; Kiers, B
– volume: 20
  start-page: 661
  issue: 4
  year: 2011
  end-page: 670
  article-title: Adipose Tissue-derived Stem Cells from Humans and Mice Differ in Proliferative Capacity and Genome Stability in Long-term Cultures
  publication-title: Stem Cells Dev
  contributor:
    fullname: Danoviz, ME; Bassaneze, V; Nakamuta, JS; Santos Junior, GR; Saint-Clair, D; Bajgelman, MC
– volume: 54
  start-page: 2277
  issue: 24
  year: 2009
  end-page: 2286
  article-title: A Randomized, Double-blind, Placebo-controlled, Dose-escalation Study of Intravenous Adult Human Mesenchymal Stem Cells (Prochymal) After Acute Myocardial Infarction
  publication-title: J Am Coll Cardiol
  contributor:
    fullname: Hare, JM; Traverse, JH; Henry, TD; Dib, N; Strumpf, RK; Schulman, SP
– volume: 22
  start-page: 1538
  issue: 4
  year: 2021
  article-title: Systematic Review: Adipose-Derived Mesenchymal Stem Cells, Platelet-Rich Plasma and Biomaterials as New Regenerative Strategies in Chronic Skin Wounds and Soft Tissue Defects
  publication-title: Int J Mol Sci
  contributor:
    fullname: Gentile, P; Garcovich, S
– volume: 21
  start-page: 1032
  issue: 8
  year: 2019
  end-page: 1041
  article-title: Rationale and Design of the European Multicentre Study on Stem Cell therapy in IschEmic Non-treatable Cardiac diseasE (SCIENCE)
  publication-title: Eur J Heart Fail
  contributor:
    fullname: Paitazoglou, C; Bergmann, MW; Vrtovec, B; Chamuleau, SAJ; van Klarenbosch, B; Wojakowski, W
– volume: 28
  start-page: 1700
  issue: 12
  year: 2019
  end-page: 1708
  article-title: Cardiac Magnetic Resonance Imaging used for Evaluation of Adipose-Derived Stromal Cell Therapy in Patients with Chronic Ischemic Heart Disease
  publication-title: Cell Transplant
  contributor:
    fullname: Qayyum, AA; Mathiasen, AB; Mygind, ND; Vejlstrup, NG; Kastrup, J
– volume: 8
  issue: 7
  year: 2013
  article-title: Porcine Adipose Tissue-derived Mesenchymal Stem Cells Retain Their Proliferative Characteristics, Senescence, Karyotype and Plasticity After Long-term Cryopreservation
  publication-title: PLoS One
  contributor:
    fullname: Dariolli, R; Bassaneze, V; Nakamuta, JS; Omae, SV; Campos, LC; Krieger, JE
– year: 2012
  publication-title: Diretrizes Metodológicas: Elaboração de Revisão Sistemática e Meta-análise de Ensaios Clínicos Randomizados
– year: 2006
  publication-title: Guidance on the Conduct of Narrative Synthesis in Systematic Reviews: A Product from the ESRC Methods Programme
  contributor:
    fullname: Popay, J; Roberts, R; Sowden, A; Petticrew, M; Arai, L; Rodgers, M
– volume: 32
  issue: 4
  year: 2019
  article-title: Transplantation of Adipose-derived Mesenchymal Stem Cells in Refractory Crohn's Disease: Systematic Review
  publication-title: Arq Bras Cir Dig
  contributor:
    fullname: Bernardi, L; Santos, CHMD; Pinheiro, VAZ; Oliveira, RJ; Antoniolli-Silva, ACMB
– volume: 17
  start-page: 305
  issue: 3
  year: 2010
  end-page: 314
  article-title: Intramyocardial Transplantation of Fibroblasts Expressing Vascular Endothelial Growth Factor Attenuates Cardiac Dysfunction
  publication-title: Gene Ther
  contributor:
    fullname: Gonçalves, GA; Vassallo, PF; Santos, L; Schettert, IT; Nakamuta, JS; Becker, C
SSID ssj0022735
Score 2.2628818
Snippet Resumo Fundamento A terapia celular utilizando células-tronco mesenquimais derivadas do tecido adiposo (ADSC, sigla em inglês) apresenta grande potencial como...
SourceID doaj
scielo
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
SubjectTerms CARDIAC & CARDIOVASCULAR SYSTEMS
Células-Tronco Mesenquimais
Isquemia Miocárdica
Medicina Regenerativa
Terapia Baseada em Transplante de Células e Tecidos
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NbtQwELZQD4gL4lcsUOQDglPUJI5Tm1vZtipIy2VbaW_WeOygSO2mbRreg0eoOKDyGnkxZpJstTcuXJLISuJofjLf2OPPQrwHDNFrExPMVZkUWQwJNWGSoqcEQykE5ERx8a08OSu-rvRqa6svrgkb6YFHwe0V2uYVGg0-9QWUFVAENaUNkEcTCd4Of99Mb5KpKdWioKxHRk1F-DzdA890hQS3DZc7b0WggaifaULJk863Q8vxE_F4woTyYPyWp-JBXD8TDxfTrPdz8XMZv3cUU_rfIKM8qmrsb0mkMoA85dVTdEl2I-f93XlHYDjh0W1s5IIXFl119QXUrTwkS_sBAVoZGnoKazodhPqyaRvJ9N9yPhSmcn01yC_tVdf_YSKBT5InD9r-VyOXbBAX_S0Pfr8QZ8dHp_OTZNpKIUECRAUdbbQxhOCtjSrTMUBleTcEE2wJ-f6-iaiNDRGND-TXVYUKLKrgi6zyAdRLsbNu1vGVkAWmFjPlMybmKdn_dZV6pnnXlpJFMxMfNuJ1lyNjhqNMY9CDIz24jR5m4jML__4mJroeGkj9blK_-5f6Z-LjqDo3-V7rlgyjHCGfVc4EbgQih_nf1_-juzfiEb90HIN5K3Zurru4S6jkxr8bDPAvpE3kuQ
  priority: 102
  providerName: Directory of Open Access Journals
Title Segurança e Eficácia da Terapia com Células-tronco Mesenquimais Derivadas do Tecido Adiposo para Cardiopatia Isquêmica: Revisão Sistemática
URI http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0066-782X2024000900304&lng=en&tlng=en
https://doaj.org/article/4592fc85ab0b4a6fa439869da2e8e049
Volume 121
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3NbtQwELaqIlVcUKEgtqWVDwhOgSR2snalqipLS0FaLtuV9mb5L1WkbbO72aDyGDxC1UNVXiMvxkySLaBy4OIkli1FnrH9fR77MyGvtXXeJMIHNmZpwCPvAsiyQWgNEAzGrLZIFIdf09Mx_zJJJr8lhboGLP9J7fA-qfFi-u5q_v0QOvwBMk5A3-F7bVCMEMC0YMDeH8WccXT2Ib8PKMQwS-NuxgjGZvijftjKbT6s_tf01Kj4o4YodLPpn_POySZ50gFGetRa-ClZmy2fkY1hFxLfIj9G_ryCCae-1dTT4yy39TW0N3WanuHRKngFp6KD-m5aAVIOcOnbFnSIp47mVX6h85J-BDf8pp0uqSugls3hceTyWVEWFLXB6aDZtYqbrzX9XM6r-ieqDOxTjCyU9U1BR-gtF_U1row_J-OT47PBadDdsxBYQEscUumld84ZKT2LEu90JvGqBOFkquN-X3ibCOm8FcZBp88yy7S0zBkeZcZp9oKsXxaX_iWh3IbSRsxEqNqT4uCQZKFBDfhEApMUPfJm1bxq1sppKKAhjR0U2EGt7NAjH7Dx7wuhCnaTUSzOVdepFE9knFmRaBMartNMA7oSqXQ69sID9emRt63p1Mqv1AgxlgJYNIlR3Q0QZhMc3v7vkjvkMX63qzCvyPpyUfldwCVLs9fweUg_TaK9xvt-ATFv5Fo
link.rule.ids 230,315,786,790,870,891,2115,24346,27955,27956
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Seguran%C3%A7a+e+Efic%C3%A1cia+da+Terapia+com+C%C3%A9lulas-tronco+Mesenquimais+Derivadas+do+Tecido+Adiposo+para+Cardiopatia+Isqu%C3%AAmica%3A+Revis%C3%A3o+Sistem%C3%A1tica&rft.jtitle=Arquivos+brasileiros+de+cardiologia&rft.au=Giugni%2C+Fernando+Rabioglio&rft.au=Giugni%2C+Melina+de+Oliveira+Valdo&rft.au=Pinesi%2C+Henrique+Trombini&rft.au=Habrum%2C+Fabio+Cetinic&rft.date=2024-01-01&rft.pub=Sociedade+Brasileira+de+Cardiologia+-+SBC&rft.issn=1678-4170&rft.volume=121&rft.issue=9&rft_id=info:doi/10.36660%2Fabc.20230830&rft.externalDocID=S0066_782X2024000900304
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0066-782X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0066-782X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0066-782X&client=summon